Last reviewed · How we verify

NCT04762290

Dance for Children With Autism

Completed NA Last updated 16 April 2025
What this trial tests

NA trial testing Dance in Neurodevelopmental Disorders in 35 participants. Completed in 31 August 2024.

Timeline
31 January 2021
Primary endpoint
30 August 2024
31 August 2024

Quick facts

Lead sponsorUniversity of California, Los Angeles
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment35
Start date31 January 2021
Primary completion30 August 2024
Estimated completion31 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, Los Angeles

Who can join

Adults 8 to 12, any sex, with Neurodevelopmental Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Motor impairments are prominent in individuals with autism spectrum disorder (ASD) and other neurodevelopment disorders, and these impairments often impact the individual's ability to engage in organized physical activity programs (OPA). While many studies have identified dance and creative movement to be retrospectively and anecdotally therapeutic, there remains a paucity of literature regarding outcomes associated with these programs, and specifically, their impact on (1) perceived and objective gross and fine motor skills, (2) perceived ability to succeed in related or divergent goals or tasks, (3) quality of life for affected individuals and their caregivers. (4) adaptive function and socialization, (5) social communication This study explores the impact of organized dance and creative movement classes on children with autism (ages 8-12) and their caregivers. Participants will complete a set of surveys and assessments designed to measure the above metrics (labeled 1, 2, and 3) at their first study visit. This initial assessment is expected to take place within two weeks prior to beginning the intervention (either a wait period or a series of 1-hour dance classes, which children will attend weekly for 10 weeks). The second and final study visit will consist of a similar set of surveys and assessments designed to measure the same metrics within the two weeks following completion of the dance class series. Participants who have completed the wait period at this point will then begin their set of 10 weekly dance classes. Expected duration of participation in the study is no longer than 14 weeks in total.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. A novel dance intervention program for children and adolescents with developmental disabilities: a pilot randomized control trial.
    Anderson JT, Toolan C, Coker E, Singer H, et al · · 2024 · cited 2× · PMID 38745176 · DOI 10.1186/s13102-024-00897-3
  2. The impact of a pilot dance intervention program for children and adolescents with developmental disabilities: a randomized control trial
    Anderson J, Toolan C, Coker E, Singer H, et al · · 2023 · DOI 10.21203/rs.3.rs-3256683/v1

Verify or expand the search:

Other trials of Dance

Trials testing the same drug.

Other recruiting trials for Neurodevelopmental Disorders

Currently open trials in the same condition.

Other University of California, Los Angeles trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04762290.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing